Text Size
27 studies found for:    " March 10, 2010":" April 09, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" March 10, 2010":" April 09, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men
Conditions: HIV Prevention;   HIV Infections
Intervention: Drug: Raltegravir
2 Not yet recruiting Adherence to HIV Therapy in Heroin Addicts
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Drug: Oral Naltrexone (ON);   Drug: Implantable Naltrexone (IN)
3 Active, not recruiting
Has Results 		Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
4 Completed
Has Results 		Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
Conditions: HIV;   Vitamin D Deficiency;   HIV Infections
Intervention: Drug: Vitamin D
5 Active, not recruiting Sustiva Levels With Use of a Gel Capsule
Conditions: HIV;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Over-encapsulated efavirenz
6 Completed
Has Results 		HIV and Fat Accumulation
Condition: HIV Infection
Intervention: Drug: Telmisartan
7 Completed TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
Condition: HIV-Infections
Intervention: Drug: etravirine
8 Completed Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
Condition: HIV Infections
Interventions: Behavioral: Project POWER HIV Risk-reduction Intervention;   Behavioral: NC DOC Standard of Care for STIs
9 Completed Vitamin D Dose Finding Study
Conditions: HIV Infections;   AIDS
Intervention: Drug: Cholecalciferol (Vit D3)
10 Recruiting Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Condition: HIV Infections
Intervention: Procedure: Blood collection
11 Active, not recruiting Using Incentives to Improve Parolee Participation and Attendance in Community Treatment
Conditions: Substance Abuse;   HIV Infections
Interventions: Behavioral: Contingency management: voucher/monetary incentives for treatment attendance;   Behavioral: Information
12 Enrolling by invitation Mesalamine to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Immune System Diseases;   Lentivirus Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso);   Drug: Placebo
13 Completed Safety of Cotrimoxazole in HIV- and HAART-exposed Infants
Conditions: Acquired Immunodeficiency Syndrome;   Infant, Newborn;   Anemia;   Neutropenia;   HIV Infections
Intervention: Drug: cotrimoxazole
14 Completed GSK1349572 Relative Bioavailability Study
Condition: HIV Infections
Interventions: Drug: GSK1349572 formulation AP;   Drug: GSK1349572 formulation AW;   Drug: GSK1349572 formulation AX
15 Completed HIV Fat Redistribution and the Evaluation of Brown Fat
Condition: HIV Infections
Intervention:
16 Active, not recruiting Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: rAd35 Env A;   Biological: rAd5 Env A;   Biological: rAd5 Env B
17 Active, not recruiting PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir
18 Active, not recruiting
Has Results 		A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
19 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Conditions: Birth Defects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
20 Completed A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: GSK2248761;   Drug: GSK2248761 + Raltegravir
To Top

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
† Indicates status has not been verified in more than two years